- Home
- CNSP vs ALBT Comparison
CNSP vs ALBT Comparison
Compare CNSP & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- ALBT
- Stock Information
- Founded
- CNSP 2017
- ALBT 2014
- Country
- CNSP United States
- ALBT United States
- Employees
- CNSP N/A
- ALBT N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNSP Health Care
- ALBT Health Care
- Exchange
- CNSP Nasdaq
- ALBT Nasdaq
- Market Cap
- CNSP 5.6M
- ALBT 5.7M
- IPO Year
- CNSP 2019
- ALBT N/A
- Fundamental
- Price
- CNSP $0.85
- ALBT $2.84
- Analyst Decision
- CNSP Hold
- ALBT
- Analyst Count
- CNSP 1
- ALBT 0
- Target Price
- CNSP N/A
- ALBT N/A
- AVG Volume (30 Days)
- CNSP 212.8K
- ALBT 94.3K
- Earning Date
- CNSP 08-13-2025
- ALBT 08-18-2025
- Dividend Yield
- CNSP N/A
- ALBT N/A
- EPS Growth
- CNSP N/A
- ALBT N/A
- EPS
- CNSP N/A
- ALBT N/A
- Revenue
- CNSP N/A
- ALBT $807,235.00
- Revenue This Year
- CNSP N/A
- ALBT N/A
- Revenue Next Year
- CNSP N/A
- ALBT N/A
- P/E Ratio
- CNSP N/A
- ALBT N/A
- Revenue Growth
- CNSP N/A
- ALBT N/A
- 52 Week Low
- CNSP $0.73
- ALBT $2.11
- 52 Week High
- CNSP $148.00
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- CNSP 42.04
- ALBT 36.71
- Support Level
- CNSP $0.73
- ALBT $2.65
- Resistance Level
- CNSP $0.90
- ALBT $3.88
- Average True Range (ATR)
- CNSP 0.07
- ALBT 0.30
- MACD
- CNSP 0.01
- ALBT -0.01
- Stochastic Oscillator
- CNSP 48.44
- ALBT 3.84
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.